A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer

被引:6
作者
Kwon, Daniel Hyuck-Min [1 ,2 ]
Friedlander, Terence [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
ABIRATERONE; THERAPY;
D O I
10.21037/atm.2019.09.21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
[21]   Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer [J].
Isaksson, Jenny ;
Green, Henrik ;
Papantoniou, Dimitrios ;
Pettersson, Linn ;
Anden, Mats ;
Rosell, Johan ;
Avall-Lundqvist, Elisabeth ;
Elander, Nils Oskar .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11) :1009-1022
[22]   Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer [J].
Bilgin, Burak ;
Sendur, Mehmet A. N. ;
Hizal, Mutlu ;
Akinci, Muhammed Bulent ;
Dede, Didem Sener ;
Yalcin, Bulent .
FUTURE ONCOLOGY, 2017, 13 (22) :1911-1913
[23]   Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons [J].
Hamid, Anis A. ;
Morris, Michael J. ;
Davis, Ian D. .
EUROPEAN UROLOGY FOCUS, 2019, 5 (02) :165-167
[24]   Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment? [J].
Adashek, Jacob J. ;
Reed, Jarred P. ;
Tandon, Ankita ;
Freedland, Stephen J. ;
Posadas, Edwin ;
Bhowmick, Neil ;
Chung, Leland W. ;
Freeman, Michael ;
Figlin, Robert A. ;
Gong, Jun .
CLINICAL GENITOURINARY CANCER, 2020, 18 (06) :425-428
[25]   Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer [J].
Yekeduz, Emre ;
McKay, Rana R. ;
Gillessen, Silke ;
Choueiri, Toni K. ;
Urun, Yuksel .
ONCOLOGIST, 2023, 28 (07) :596-603
[26]   Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration [J].
Freedland, Stephen J. ;
Sandin, Rickard ;
Sah, Janvi ;
Emir, Birol ;
Mu, Qiao ;
Ratiu, Anna ;
Hong, Agnes ;
Serfass, Lucile ;
Tagawa, Scott T. .
CANCER MEDICINE, 2021, 10 (23) :8570-8580
[27]   Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting [J].
Sayegh, Nicolas ;
Tripathi, Nishita ;
Nussenzveig, Roberto H. ;
Thomas, Vinay Mathew ;
Tandar, Clara ;
Goel, Divyam ;
Nordblad, Blake ;
Sahu, Kamal Kant ;
Li, Haoran ;
Maughan, Benjamin L. ;
Agarwal, Neeraj ;
Swami, Umang .
EUROPEAN UROLOGY FOCUS, 2023, 9 (01) :106-109
[28]   PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer [J].
Sutera, Philip ;
Kim, Jongmyung ;
Kumar, Ritesh ;
Deek, Rebecca A. ;
Stephenson, Ryan ;
Mayer, Tina ;
Saraiya, Biren ;
Ghodoussipour, Saum ;
Jang, Thomas ;
Golombos, David ;
Packiam, Vignesh ;
Ennis, Ronald ;
Hathout, Lara ;
Jabbour, Salma K. ;
Guler, Ozan ;
Onal, Cem ;
Tran, Phuoc T. ;
Deek, Matthew P. .
PROSTATE, 2024, 84 (14) :1301-1308
[29]   APPROACH TO THE TREATMENT OF METASTATIC CASTRATION-SENSITIVE PROSTATE CARCINOMA: A SINGLE CENTER EXPERIENCE [J].
Semiz, Huseyin Salih ;
Keskinkilic, Merve ;
Ellez, Halil Ibrahim ;
Arayici, Mehmet Emin ;
Karaoglu, Aziz .
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2022, 6 (01) :296-304
[30]   HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer [J].
Hearn, Jason W. D. ;
Sweeney, Christopher J. ;
Almassi, Nima ;
Reichard, Chad A. ;
Reddy, Chandana A. ;
Li, Hong ;
Hobbs, Brian ;
Jarrard, David F. ;
Chen, Yu-Hui ;
Dreicer, Robert ;
Garcia, Jorge A. ;
Carducci, Michael A. ;
DiPaola, Robert S. ;
Sharifi, Nima .
JAMA ONCOLOGY, 2020, 6 (04)